News & Updates

Show Multimedia Only

New data support B/FTC/TAF use in HIV+ children

21 Mar 2023 by

Data from a French study presented at CROI 2023 support the use of bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg (B/FTC/TAF) in the management of paediatric patients with HIV.

New data support B/FTC/TAF use in HIV+ children

21 Mar 2023

Rifaximin helps improve symptoms of IBS with diarrhoea

21 Mar 2023

Treatment with rifaximin appears to produce significant reductions in multiple, concurrent symptoms of irritable bowel syndrome (IBS) with diarrhoea, according to a study that uses a novel tri-symptom endpoint.

Rifaximin helps improve symptoms of IBS with diarrhoea

21 Mar 2023

Bempedoic acid cuts CV events in statin-intolerant patients

21 Mar 2023 by

The use of bempedoic acid significantly reduced the risk of major adverse cardiovascular events (MACE) in patients with high cholesterol who are intolerant to statins in the phase III CLEAR* Outcomes trial presented at ACC.23/WCC.

Bempedoic acid cuts CV events in statin-intolerant patients

21 Mar 2023

PCSK9 inhibition tied to decreased psoriasis risk

20 Mar 2023 by

Inhibition of the proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway appears to be causally associated with a lower risk of psoriasis, regardless of the concentration levels of circulating low-density lipoprotein (LDL), according a two-sample Mendelian randomization study.

PCSK9 inhibition tied to decreased psoriasis risk

20 Mar 2023

Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers

20 Mar 2023

Use of telbivudine (LdT) during the second trimester of pregnancy helps prevent mother-to-child transmission of hepatitis B virus, reveals a study. In addition, treatment with LdT during pregnancy is safe in the long term for both mothers and infants.

Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers

20 Mar 2023

ICD maintains shock function after MRI

20 Mar 2023 by

Non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs) are effective at treating detected tachyarrhythmias after MRI, with no serious adverse effects on device function seen, reports a study.

ICD maintains shock function after MRI

20 Mar 2023

High iron level ups risk of noncommunicable disease in adolescents

20 Mar 2023

A recent study in India has found a significant association between high serum ferritin (SF) and noncommunicable disease (NCD) in adolescents. Additionally, such interaction is dependent on wealth and coexisting prediabetes.

High iron level ups risk of noncommunicable disease in adolescents

20 Mar 2023

Long-term OLE boosts potential of remibrutinib for CSU

20 Mar 2023 by

In the 52-week open-label extension (OLE) of a phase IIb study presented at AAAAI 2023, the BTK* inhibitor remibrutinib demonstrated sustained efficacy and a favourable safety profile for the treatment of chronic spontaneous urticaria (CSU).